Packaging and storage
Preserve in single-dose containers,preferably of Type Ior Type IIglass,or of a suitable plastic material.
Identification
A:
The UVabsorption spectrum of the Injection,diluted with 0.5Nsodium hydroxide to a concentration of about 8µg of anhydrous theophylline per mL,exhibits maxima and minima at the same wavelengths as that of a similar solution of
USP Theophylline RS,concomitantly measured.
B:
Add a few drops of the Injection to 5mLof hot alkaline cupric tartrate TS:a red to orange precipitate of cuprous oxide is formed.
pHá791ñ:
between 3.5and 6.5,determined on a portion diluted with water,if necessary,to a concentration of not more than 5%of dextrose.
Limit of 5-hydroxymethylfurfural and related substances
Cation-exchange column
Proceed as directed under
Column Partition Chromatography(see
Chromatography á621ñ),using a chromatographic tube capable of providing a 0.8-×4-cm bed volume (or about 2mL)of 100-to 200-mesh,strongly acidic,styrene-divinylbenzene,cation-exchange resin.Condition the column by washing with about 30mLof water,discarding the eluate.
Procedure
Pass a volume of Injection containing about 100mg of hydrous dextrose through the resin bed in the Cation-exchange column,allowing the specimen to flow down the wall of the column so as not to disturb the resin bed,and collect the eluate in a 50-mLvolumetric flask.Wash the column with 25mLof water,and collect the eluate in the same 50-mLvolumetric flask.Dilute the eluate with water to volume,and mix to obtain the Test solution.In a similar manner,prepare a Reference solutionby passing 27mLof water through a freshly conditioned Cation-exchange column,collecting the eluate in a 50-mLvolumetric flask.Dilute with water to volume,and mix.Determine the absorbance of the Test solutionin a 1-cm cell at 284nm,with a suitable spectrophotometer,using the Reference solutionas the blank:the absorbance is not more than 0.25.
Assay for theophylline
Buffer solution,
Mobile phase,and Internal standard solutionPrepare as directed in the Assayunder Theophylline.
Standard preparation
Dissolve an accurately weighed quantity of
USP Theophylline RSin
Mobile phase,and dilute quantitatively,and stepwise if necessary,with
Mobile phaseto obtain a solution having a known concentration of about 1mg per mL.Transfer 8.0mLof this solution to a 50-mLvolumetric flask,add 10.0mLof
Internal standard solution,dilute with
Mobile phaseto volume,and mix to obtain a solution having a known concentration of about 0.16mg of
USP Theophylline RSper mL.
Assay preparation
Transfer an accurately measured volume of Injection,equivalent to about 16mg of theophylline,to a 100-mLvolumetric flask,add 20.0mLof Internal standard solution,dilute with Mobile phaseto volume,and mix.
Procedure
Proceed as directed for
Procedurein the
Assayunder
Theophylline.Calculate the quantity,in mg,of C
7H
8N
4O
2in each mLof the Injection taken by the formula:
(100C/V)(RU/RS),
in which
Vis the volume,in mL,of Injection taken,and the other terms are as defined therein.
Assay for dextrose
Transfer an accurately measured volume of Injection,containing 2to 5g of dextrose,to a 100-mLvolumetric flask.Add 0.2mLof 6Nammonium hydroxide,dilute with water to volume,and mix.Determine the angular rotation in a suitable polarimeter tube at 25

(see
Optical Rotation á781ñ).The observed rotation,in degrees multiplied by 1.0425
A,in which
Ais the ratio 200divided by the length,in mm,of the polarimeter tube employed,represents the weight,in g,of C
6H
12O
6·H
2Oin the volume of Injection taken.
Auxiliary Information
Staff Liaison:
Karen A Russo,Ph.D.,Scientist
Expert Committee:(PA1)Pharmaceutical Analysis 1
USP28NF23Page 1899
Pharmacopeial Forum:Volume No.30(5)Page 1649
Phone Number:1-301-816-8379